Summary of Significant Accounting Policies (Tables)

9 Months Ended

Apr. 30, 2020

Accounting Policies [Abstract]

Schedule of revenue recognized

	Three months ended April 30,					Nine months ended April 30,
Revenue Source	2020		2019			2020		2019
Product sales	$	497,386	$	37,300		$	2,059,662	$	37,300
Management services		1,290		80,472			18,168		283,319
Pharmacy sales		—		1,020,616			—		5,615,153
Laboratory sales		—		(45,461	)		—		318,567
Total Revenue	$	498,676	$	1,092,926		$	2,077,830	$	6,254,339